Development, Hirshfeld surface analysis, DFT calculations and biological evaluation of Neratinib loaded Co-crystals for solubility enhancement
This study successfully developed and optimized neratinib–3-hydroxybenzoic acid co-crystals using rational design and DFT calculations, achieving significant improvements in solubility, dissolution, and cytotoxicity against HER2-positive breast cancer cells compared to the pure drug.